Discovery and Characterization of DCAF5: A Key Regulator of T-cell Development and Function

Target Name: DCAF5

NCBI ID: G8816

DCAF5

Discovery and Characterization of DCAF5: A Key Regulator of T-cell Development and Function

DCAF5 is a protein that is expressed in various tissues throughout the body. It is a member of the superfamily of core subunits of the kappa E2 adaptor, which is a protein that is involved in the intracellular signaling pathway known as the T-cell signaling pathway. DCAF5 is a key regulator of this pathway and is involved in the development and maintenance of T-cell responses to foreign antigens.

The DDB1 gene encodes the protein DCAF5, which is a 128 amino acid protein that contains several important functions in various biological processes. One of the most significant functions of DCAF5 is its role in the regulation of T-cell development and function. DCAF5 plays a critical role in the development of T-cells and in the regulation of their subsetting and activation.

In addition to its role in T-cell development, DCAF5 is also involved in the regulation of other cellular processes. For example, DCAF5 has been shown to play a key role in the regulation of cell adhesion and in the development of cancer. DCAF5 has also been shown to be involved in the regulation of inflammation and immune responses.

DCAF5 is also a potential drug target and biomarker. The ability of DCAF5 to regulate T-cell responses to foreign antigens makes it an attractive target for the development of new therapies for various diseases. In addition, the regulation of T-cell development and function by DCAF5 is also a potential target for cancer therapies.

Discovery and Characterization of DCAF5

The study of DCAF5 was first described in 2004 by researchers at the University of California, San Diego. This study identified a new protein that was expressed in various tissues and was shown to play a critical role in the regulation of T-cell development and function.

Since then, researchers have continued to study the functions of DCAF5 and its potential as a drug target. One of the most significant findings of these studies is the role of DCAF5 in the regulation of T-cell sensitivity to chemotherapy. Studies have shown that DCAF5 plays a critical role in the development of T-cell tolerance to chemotherapy and that inhibiting its function can lead to increased T-cell sensitivity to this treatment.

Another area of research for DCAF5 is its role in the regulation of T-cell immunity to viral infections. Studies have shown that DCAF5 plays a critical role in the regulation of T-cell responses to viral infections and that its function in this pathway is critical for the development of effective vaccines.

DCAF5 is also involved in the regulation of T-cell responses to cancer. Studies have shown that DCAF5 plays a critical role in the regulation of T-cell sensitivity to cancer and that its function in this pathway is important for the development of effective cancer therapies.

Potential Therapies for DCAF5

The potential therapies for DCAF5 are currently being investigated as a potential drug target and biomarker for various diseases. One of the most promising areas of research for DCAF5 is its potential as a cancer therapeutic.

One of the main advantages of DCAF5 as a cancer therapeutic is its ability to selectively target T-cells. Because DCAF5 is only expressed in T-cells, it is possible to specifically target this protein and inhibit its function without affecting other cell types. This can lead to more effective and less toxic treatments.

Another potential therapy for DCAF5 is its ability to enhance the effectiveness of

Protein Name: DDB1 And CUL4 Associated Factor 5

Functions: Is a substrate receptor for the CUL4-DDB1 E3 ubiquitin-protein ligase complex (CRL4) (PubMed:29691401, PubMed:30442713). The complex CRL4-DCAF5 is involved in the ubiquitination of a set of methylated non-histone proteins, including SOX2, DNMT1 and E2F1 (PubMed:29691401, PubMed:30442713)

The "DCAF5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DCAF5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets